S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Galmed Pharmaceuticals (GLMD) Institutional Ownership

$0.37
-0.01 (-2.61%)
(As of 04/19/2024 ET)

Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)

Current
Institutional Ownership
Percentage
76.14%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$154.85K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$6.17M
Get GLMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

GLMD Institutional Buying and Selling by Quarter

Galmed Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2023Walleye Capital LLC249,763$155K0.0%N/A14.867%
8/15/2023BVF Inc. IL89,853$261K0.0%-93.3%5.348%
5/16/2023BVF Inc. IL1,347,755$575K0.0%-22.5%5.348%
2/15/2023Millennium Management LLC149,217$75K0.0%+218.4%0.595%
2/8/2023Raymond James & Associates138,040$69K0.0%-11.5%0.550%
8/15/2022Millennium Management LLC50,748$35K0.0%+372.3%0.202%
7/18/2022Western Wealth Management LLC59,074$38K0.0%N/A0.235%
5/13/2022Nantahala Capital Management LLC258,957$412K0.0%-13.1%1.032%
5/12/2022Cambridge Investment Research Advisors Inc.26,115$42K0.0%N/A0.104%
5/11/2022Raymond James Financial Services Advisors Inc.63,310$101K0.0%+158.9%0.252%
2/8/2022Raymond James & Associates203,540$370K0.0%-11.4%0.811%
2/7/2022Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485%
11/16/2021Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101%
11/16/2021Toroso Investments LLC24,657$69K0.0%N/A0.098%
11/5/2021Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756%
11/2/2021Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085%
11/2/2021Raymond James & Associates229,640$641K0.0%+10.5%0.915%
8/16/2021Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130%
8/16/2021Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766%
8/16/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867%
8/5/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.868%
7/31/2021Brave Asset Management Inc.11,470$35K0.0%N/A0.046%
5/19/2021Squarepoint Ops LLC54,884$188K0.0%+161.2%0.219%
5/17/2021Goldman Sachs Group Inc.26,419$91K0.0%N/A0.105%
5/14/2021Nantahala Capital Management LLC1,213,540$4.16M0.1%-37.0%4.838%
5/13/2021Renaissance Technologies LLC60,700$208K0.0%-47.6%0.242%
3/26/2021Susquehanna International Group LLP10,483$33K0.0%N/A0.042%
2/16/2021Squarepoint Ops LLC21,010$65K0.0%-12.5%0.100%
2/16/2021Baker BROS. Advisors LP184,927$575K0.0%-10.0%0.876%
2/10/2021Renaissance Technologies LLC115,800$360K0.0%+238.2%0.548%
2/3/2021Ibex Investors LLC1,525,000$4.74M1.9%+0.7%7.223%
11/16/2020Squarepoint Ops LLC24,024$85K0.0%N/A0.114%
11/13/2020Morgan Stanley130,165$459K0.0%+17.6%0.617%
11/12/2020Voss Capital LLC125,000$443K0.3%-6.6%0.592%
11/10/2020Phoenix Holdings Ltd.145,865$480K0.0%+8.5%0.691%
11/9/2020P.A.W. Capital Corp200,000$706K0.8%+100.0%0.947%
11/4/2020Raymond James & Associates228,569$807K0.0%-57.2%1.083%
11/3/2020Ibex Investors LLC1,515,000$5.35M2.8%+53.8%7.176%
10/20/2020Wedbush Securities Inc.13,003$46K0.0%N/A0.062%
8/14/2020Nantahala Capital Management LLC2,072,745$9.91M0.3%+59.0%9.817%
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
8/14/2020BVF Inc. IL1,799,694$8.60M0.5%-1.8%8.524%
8/12/2020Ibex Investors LLC985,000$4.71M2.2%+2.1%4.665%
7/28/2020Raymond James & Associates534,609$2.56M0.0%+55.3%2.532%
5/20/2020Phoenix Holdings Ltd.75,383$253K0.0%+312.9%0.357%
5/18/2020Vivo Capital LLC860,103$2.98M0.3%N/A4.069%
5/15/2020Squarepoint Ops LLC34,350$119K0.0%+238.9%0.162%
5/15/2020Voss Capital LLC159,454$319K0.4%+5.9%0.754%
5/15/2020Morgan Stanley77,552$269K0.0%+24.6%0.367%
5/15/2020Two Sigma Securities LLC16,330$57K0.0%N/A0.077%
5/14/2020Ibex Investors LLC965,000$3.34M3.4%+1.0%4.565%
5/14/2020ETF Managers Group LLC41,548$143K0.0%+9.8%0.197%
4/21/2020Raymond James & Associates344,195$1.19M0.0%-14.7%1.628%
(Data available from 1/1/2016 forward)

GLMD Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GLMD shares?

During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: Nantahala Capital Management LLC ($412K), BVF Inc. IL ($261K), Walleye Capital LLC ($155K), Raymond James Financial Services Advisors Inc. ($101K), Millennium Management LLC ($75K), Raymond James & Associates ($69K), and Cambridge Investment Research Advisors Inc. ($42K).Learn more on GLMD's institutional investors.

What percentage of Galmed Pharmaceuticals stock is owned by institutional investors?

76.14% of Galmed Pharmaceuticals stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings.

Which institutional investors have been buying Galmed Pharmaceuticals stock?

The following institutional investors have purchased Galmed Pharmaceuticals stock in the last 24 months: Walleye Capital LLC ($249.76K), Millennium Management LLC ($142.35K), Western Wealth Management LLC ($59.07K), Raymond James Financial Services Advisors Inc. ($38.86K), and Cambridge Investment Research Advisors Inc. ($26.12K).

How much institutional buying is happening at Galmed Pharmaceuticals?

Institutional investors have bought a total of 516,162 shares in the last 24 months. This purchase volume represents approximately $3.44M in transactions.

Which Galmed Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Galmed Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.65M), Nantahala Capital Management LLC ($38.99K), and Raymond James & Associates ($17.90K).

How much institutional selling is happening at Galmed Pharmaceuticals?

Institutional investors have sold a total of 1,706,707 shares in the last 24 months. This volume of shares sold represents approximately $7.23M in transactions.


This page (NASDAQ:GLMD) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners